Abstract
Background: Although the forced expiratory flow parameters are increasingly used in the diagnosis of small airway disease (SAD), the reversibility of these indicators is rarely described. The aim of this study is to evaluate the association of small airways reversibility with the presence of SAD and bronchodilator reversibility (BDR) of the proximal airways. Methods: The forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and the indicators of SAD (FEF25%, FEF50%, FEF75%, FEF25-75%, and FEF75-85%) were measured before and 20 minutes after salbutamol administration (200 mcg by using inhaler/Spacer). Positive BDR was accepted when FEV1 or FVC was increased ? 12% and > 200 ml, indicating responsive proximal airways. Positive small airway reversibility was diagnosed when any of the small airway indicators is increased ? 30% above the baseline results. All measurements were performed with the All-flow spirometer (Clement Clarke International, Harlow, UK). Results: Evidence of SAD was found in 62.1% of all participants and in 75.2% of those who showed responsive proximal airways. The positive predictive value of the SAD in diagnosing responsive proximal airways was 67.8%. The reversibility of the small airway indicators showed insignificant association with the FEV1 or FVC BDR. The reversibility of FEF50%, FEF75% and FEF25-75% showed significant association with the diagnosis of SAD, with specificities ranging from 75.5%-81.1%. Conclusion: SAD has a significant association with positive reversibility of both the proximal and the peripheral airways. Further studies are needed to evaluate the clinical significance of positive small airway reversibility in the diagnosis and management of obstructive lung diseases. Keywords: Asthma; Small airway disease; Bronchodilator Reversibility, FEV1, FVC; FEF25-75%
Highlights
Asthma is a chronic airway disease that affects about 300 million people worldwide and cause negative impact on their social, economic and overall quality of life [1]
Many of the asthmatic patients who attend asthma clinics with respiratory symptoms might show non-obstructive patterns on spirometry; a significant proportion of them might be responsive to the bronchodilator [14]
It is recommended that all patients who perform spirometry should do the bronchodilator reversibility (BDR) testing, even when there is no evidence of obstruction
Summary
Asthma is a chronic airway disease that affects about 300 million people worldwide and cause negative impact on their social, economic and overall quality of life [1]. A positive BDR is a valuable step in asthma diagnosis It is reported when either FEV1 or FVC is increased ≥ 12% (and 200 ml absolute value) after inhalation of a short acting bronchodilator. The FEV1 and FVC BDR evaluates obstruction within the proximal airways It is helpful in the diagnosis of significant proportions of asthmatic patients, who present with normal or non-obstructive patterns on spirometry [5]. Positive BDR was accepted when FEV1 or FVC was increased ≥ 12% and > 200 ml, indicating responsive proximal airways. The reversibility of the small airway indicators showed insignificant association with the FEV1 or FVC BDR. Further studies are needed to evaluate the clinical significance of positive small airway reversibility in the diagnosis and management of obstructive lung diseases.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Medical and Biomedical Studies
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
